Cargando…

Is there an underlying link between COVID-19, ACE2, oxytocin and vitamin D?

Detalles Bibliográficos
Autor principal:	Diep, Phuoc-Tan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657032/ https://www.ncbi.nlm.nih.gov/pubmed/33214002 http://dx.doi.org/10.1016/j.mehy.2020.110360

Ejemplares similares

Oxytocin, A Possible Treatment for Covid-19? Everything to Gain, Nothing to Lose
por: Diep, Phuoc-Tan, et al.
Publicado: (2020)

Could oxytocin reduce autoimmune disease in COVID-19?
por: Diep, Phuoc-Tan, et al.
Publicado: (2022)

Hypothesis: Oxytocin is a direct COVID-19 antiviral
por: Diep, Phuoc-Tan, et al.
Publicado: (2020)

Vitamin D binding protein and its polymorphisms may explain the link between vitamin D deficiency and COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

ACEs family genes: Important molecular links between lung cancer and COVID‐19
por: Zhang, Yinjiang, et al.
Publicado: (2021)

Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Authors’ Reply: Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Charoenngam, Nipith, et al.
Publicado: (2021)

Is There a Link between COVID-19 Mortality with Genus, Age, ABO Blood Group Type, and ACE2 Gene Polymorphism?
por: CHEGNI, Hamid, et al.
Publicado: (2020)

Association between low vitamin D and COVID-19: don’t forget the vitamin D binding protein
por: Speeckaert, Marijn M., et al.
Publicado: (2020)

Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways
por: Dalan, Rinkoo, et al.
Publicado: (2021)

COVID-19 and Comorbid Hypertension: Is ACE2 the Culprit?
por: Zhang, Ting, et al.
Publicado: (2020)

Obesity and COVID-19: ACE 2, the Missing Tile
por: Iannelli, Antonio, et al.
Publicado: (2020)

ACE polymorphism and COVID-19 outcome
por: Delanghe, Joris R., et al.
Publicado: (2020)

Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?
por: Guler, Nil, et al.
Publicado: (2020)

ACE2, a drug target for COVID-19 treatment?
por: Liu, Yang, et al.
Publicado: (2022)

RAAS-Blockade in COVID-19: The Ace of Spades?
por: Agarwal, Krishna A., et al.
Publicado: (2021)

Role of Vitamin D in COVID-19: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19
por: Valenzuela, Rita, et al.
Publicado: (2021)

Vitamin D and uric acid: Is parathyroid hormone the missing link?
por: Ponvilawan, Ben, et al.
Publicado: (2021)

Vitamin D status and COVID-19 in older adults
por: Mandal, Amit K. J., et al.
Publicado: (2020)

Prognostic implications of vitamin D in patients with COVID-19
por: Hosack, Tom, et al.
Publicado: (2020)

Role of vitamin D deficiency and comorbidities in COVID-19
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2022)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

The link between COVID-19 and preeclampsia
por: Papageorghiou, Aris T., et al.
Publicado: (2022)

Sex-specific association between vitamin D deficiency and COVID-19 mortality in older patients
por: Hars, M., et al.
Publicado: (2020)

Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction
por: Ren, Yongwen, et al.
Publicado: (2022)

ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe
por: Ristić, Smiljana, et al.
Publicado: (2021)

Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
por: Brogi, Simone, et al.
Publicado: (2020)

Vitamin D supplementation in COVID-19: A friend or foe?
por: Mansour, Asieh, et al.
Publicado: (2020)

Is Vitamin D One of the Key Elements in COVID-19 Days?
por: Aslan, M. T., et al.
Publicado: (2020)

Role of Vitamin D Supplementation in Prevention and Treatment of COVID-19
por: Khemka, Aakriti, et al.
Publicado: (2020)

Reply to: Prognostic implications of vitamin D in patients with COVID-19
por: Hastie, Claire E., et al.
Publicado: (2020)

Spurious undermining of the adjuvant role of vitamin D in COVID-19
por: Pal, Rimesh, et al.
Publicado: (2021)

Vitamin D(3) Administration to Patients with Confirmed COVID-19
por: RASHEDI, Jalil, et al.
Publicado: (2020)

Increased risk for Covid-19 in patients with Vitamin D deficiency
por: Katz, Joseph
Publicado: (2021)

Vitamin D levels and COVID 19 risk and death; is there an association?
por: Al Kiyumi, Maisa Hamed
Publicado: (2022)

Vitamin D Supplementation Should Be Considered for the Treatment of COVID-19 Infection in Malaysia in View of the High Prevalence of Vitamin D Deficiency
por: MOHD SAFFIAN, Shamin
Publicado: (2021)

Comment on “Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management”
por: Sahin, Mustafa, et al.
Publicado: (2020)

ACE2 mutation might explain lower COVID-19 burden in malaria endemic areas
por: De, Auley, et al.
Publicado: (2021)

COVID-19 and misinformation: how an infodemic fuelled the prominence of vitamin D
por: Henrina, Joshua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_87d3vttct1b8fnvu30nak8c7vg